In8bio Inc Stock Chance of Future Stock Price Finishing Over 0.3
INAB Stock | USD 0.30 0.01 3.23% |
In8bio |
In8bio Target Price Odds to finish over 0.3
The tendency of In8bio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
0.30 | 90 days | 0.30 | about 61.29 |
Based on a normal probability distribution, the odds of In8bio to move above the current price in 90 days from now is about 61.29 (This In8bio Inc probability density function shows the probability of In8bio Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days In8bio Inc has a beta of -1.33. This usually indicates as returns on its benchmark rise, returns on holding In8bio Inc are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, In8bio is expected to outperform its benchmark. Additionally In8bio Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. In8bio Price Density |
Price |
Predictive Modules for In8bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as In8bio Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.In8bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. In8bio is not an exception. The market had few large corrections towards the In8bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold In8bio Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of In8bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.08 | |
β | Beta against Dow Jones | -1.33 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | -0.03 |
In8bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of In8bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for In8bio Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.In8bio Inc generated a negative expected return over the last 90 days | |
In8bio Inc has high historical volatility and very poor performance | |
In8bio Inc has some characteristics of a very speculative penny stock | |
In8bio Inc has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (30.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
In8bio Inc currently holds about 25.74 M in cash with (23.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
In8bio Inc has a poor financial position based on the latest SEC disclosures | |
Roughly 22.0% of the company shares are held by company insiders | |
Latest headline from finance.yahoo.com: IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral Presentation at the Society for Neuro-Oncology Annual Meeting |
In8bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of In8bio Stock often depends not only on the future outlook of the current and potential In8bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. In8bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 29.9 M | |
Cash And Short Term Investments | 21.3 M |
In8bio Technical Analysis
In8bio's future price can be derived by breaking down and analyzing its technical indicators over time. In8bio Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of In8bio Inc. In general, you should focus on analyzing In8bio Stock price patterns and their correlations with different microeconomic environments and drivers.
In8bio Predictive Forecast Models
In8bio's time-series forecasting models is one of many In8bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary In8bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about In8bio Inc
Checking the ongoing alerts about In8bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for In8bio Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
In8bio Inc generated a negative expected return over the last 90 days | |
In8bio Inc has high historical volatility and very poor performance | |
In8bio Inc has some characteristics of a very speculative penny stock | |
In8bio Inc has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (30.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
In8bio Inc currently holds about 25.74 M in cash with (23.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
In8bio Inc has a poor financial position based on the latest SEC disclosures | |
Roughly 22.0% of the company shares are held by company insiders | |
Latest headline from finance.yahoo.com: IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral Presentation at the Society for Neuro-Oncology Annual Meeting |
Check out In8bio Backtesting, In8bio Valuation, In8bio Correlation, In8bio Hype Analysis, In8bio Volatility, In8bio History as well as In8bio Performance. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.74) | Return On Assets (0.78) | Return On Equity (1.80) |
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.